Phathom Pharmaceuticals, Inc. (PHAT)
USD 3.9
(-3.23%)
USD 3.9
(-3.23%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 682 Thousand | - | - | - | - | - |
| Cost of Revenue | 167 Thousand | 620 Thousand | 521 Thousand | 300 Thousand | 8000.00 | - |
| Gross Profit | 515 Thousand | -620 Thousand | -521 Thousand | -300 Thousand | -8000.00 | - |
| Operating Expenses | 167.82 Million | 172.44 Million | 135.08 Million | 125.66 Million | 106.21 Million | 1.22 Million |
| Selling, General and Administrative Expenses | 117.92 Million | 100.99 Million | 62.74 Million | 27.51 Million | 6.94 Million | 1.2 Million |
| Research and Development Expenses | 49.89 Million | 71.44 Million | 72.33 Million | 98.14 Million | 99.27 Million | 20 Thousand |
| Other Expenses | - | -110 Thousand | -2.05 Million | -8000.00 | -49.55 Million | -50 Thousand |
| Cost and Expenses | 167.99 Million | 172.44 Million | 135.08 Million | 125.66 Million | 106.21 Million | 1.22 Million |
| Operating Income | -167.31 Million | -172.44 Million | -135.08 Million | -125.66 Million | -106.21 Million | -1.22 Million |
| Interest Expense | 41.96 Million | 27.3 Million | 6.78 Million | 4.58 Million | 4.17 Million | 13 Thousand |
| Income Tax Expense | - | 25.28 Million | 4.21 Million | 4.25 Million | -45.38 Million | 13 Thousand |
| Earnings before Tax | -201.59 Million | -197.72 Million | -143.88 Million | -129.06 Million | -255.13 Million | -1.28 Million |
| Net Income | -201.59 Million | -223 Million | -148.09 Million | -133.31 Million | -209.74 Million | -1.28 Million |
| Earnings Per Share Basic | -3.93 | -5.70 | -4.00 | -4.01 | -8.48 | -0.15 |
| Earnings Per Share Diluted | -3.93 | -5.70 | -4.00 | -4.01 | -8.48 | -0.15 |
| Weighted Average Shares Outstanding | 51.28 Million | 39.11 Million | 37 Million | 33.22 Million | 24.72 Million | 8.57 Million |
| Weighted Average Shares Outstanding (Diluted) | 51.28 Million | 39.11 Million | 37 Million | 33.22 Million | 24.72 Million | 8.57 Million |
| Gross Margin | 0.76 | - | - | - | - | - |
| EBIT Margin | -233.21 | - | - | - | - | - |
| Profit Margin | -295.59 | - | - | - | - | - |
| EBITDA | -159.04 Million | -171.82 Million | -134.55 Million | -124.18 Million | -250.94 Million | -50 Thousand |
| Earnings Before Tax Margin | -245.33 | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 7.32 Million | 1.91 Million | 682 Thousand | 682 Thousand | - | - |
| Cost of Revenue | 1.37 Million | 426 Thousand | -223 Thousand | 167 Thousand | 121 Thousand | 123 Thousand |
| Gross Profit | 5.94 Million | 1.48 Million | 905 Thousand | 515 Thousand | -121 Thousand | -123 Thousand |
| Operating Expenses | 83.24 Million | 71.44 Million | 70.39 Million | 167.82 Million | 35.65 Million | 31.7 Million |
| Selling, General and Administrative Expenses | 75.87 Million | 62.01 Million | 56.99 Million | - | 23.39 Million | 18.93 Million |
| Research and Development Expenses | 7.37 Million | 9.43 Million | 13.39 Million | - | 12.26 Million | 12.76 Million |
| Other Expenses | -6000.00 | -43 Thousand | -14 Thousand | -188 Thousand | -197 Thousand | 3000.00 |
| Cost and Expenses | 84.62 Million | 71.86 Million | 70.55 Million | 167.99 Million | 35.65 Million | 31.7 Million |
| Operating Income | -77.3 Million | -69.95 Million | -69.87 Million | -167.31 Million | -35.65 Million | -31.7 Million |
| Interest Expense | 17.76 Million | 17.16 Million | 13.02 Million | 41.96 Million | -10.1 Million | 9.61 Million |
| Income Tax Expense | - | 170.72 Thousand | -16.73 Million | 41.78 Million | 7.26 Million | 9.61 Million |
| Earnings before Tax | -91.44 Million | -82.85 Million | -79.57 Million | -201.59 Million | -43.24 Million | -40.96 Million |
| Net Income | -91.44 Million | -82.85 Million | -79.57 Million | -201.59 Million | -43.24 Million | -40.96 Million |
| Earnings Per Share Basic | -1.56 | -1.42 | -1.39 | - | -0.76 | -0.84 |
| Earnings Per Share Diluted | -1.56 | -1.42 | -1.39 | - | -0.76 | -0.84 |
| Weighted Average Shares Outstanding | 58.55 Million | 58.37 Million | 57.29 Million | 51.28 Million | 56.78 Million | 48.5 Million |
| Weighted Average Shares Outstanding (Diluted) | 58.55 Million | 58.37 Million | 57.29 Million | 51.28 Million | 56.78 Million | 48.5 Million |
| Gross Margin | 0.81 | 0.78 | 1.33 | 0.76 | - | - |
| EBIT Margin | -10.53 | -36.47 | -97.30 | - | - | - |
| Profit Margin | -12.49 | -43.33 | -116.67 | -295.59 | - | - |
| EBITDA | -77.1 Million | -69.74 Million | -66.35 Million | - | -35.65 Million | -31.22 Million |
| Earnings Before Tax Margin | -10.55 | -36.59 | -102.46 | -245.33 | - | - |
0KIT
9684
002651
BCPPF
KTF
NEMKY